Ascentage Pharma Group International (AAPG) Intangibles (2023 - 2026)

Ascentage Pharma Group International's Intangibles history runs 4 years deep, the most recent figure standing at $9.3 million for Q4 2025.

• In Q4 2025, Intangibles fell 12.13% year-over-year to $9.3 million; the TTM figure through Dec 2025 stood at $9.3 million (down 12.13% YoY), while the FY2025 annual figure was $9.4 million, down 9.44% from the prior year.
• Intangibles for Q4 2025 stood at $9.3 million, down from $9.9 million in the prior quarter.
• The five-year high for Intangibles was $10.6 million in Q4 2024, with the low at $3.8 million in Q4 2023.
• The 4-year median for Intangibles is $9.3 million (2025), against an average of $7.5 million.
• The sharpest annual moves came in 2024 and 2025: Intangibles surged 180.84% in 2024, then decreased 12.13% in 2025.
• Ascentage Pharma Group International's Intangibles stood at $4.0 million in 2022, then retreated by 6.4% to $3.8 million in 2023, then soared by 180.84% to $10.6 million in 2024, then dropped by 12.13% to $9.3 million in 2025.
• Business Quant data shows AAPG's Intangibles at $9.3 million in Q4 2025, $9.9 million in Q2 2025, and $10.6 million in Q4 2024.